NEUROBLASTOMA
Clinical trials for NEUROBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new NEUROBLASTOMA trials appear
Sign up with your email to follow new studies for NEUROBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising radioactive therapy for childhood cancer tested, but trial stopped early
Disease control TerminatedThis study tested a radioactive drug called 67Cu-SARTATE in 21 children with high-risk neuroblastoma, a serious nerve cancer. The goal was to find the safest dose and see if it could shrink tumors. The trial was terminated early, so results are limited, but it aimed to control th…
Matched conditions: NEUROBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: Clarity Pharmaceuticals Ltd • Aim: Disease control
Last updated May 26, 2026 06:07 UTC
-
Promising combo for childhood cancer halted early
Disease control TerminatedThis early-phase study tested a new drug combination (ribociclib plus topotecan and temozolomide) in children and young adults with relapsed or hard-to-treat neuroblastoma and other solid tumors. The goal was to find a safe dose and see if it could shrink tumors. Only 12 people t…
Matched conditions: NEUROBLASTOMA
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 06:05 UTC
-
Tailored cancer cocktail fails to advance in Kids' neuroblastoma trial
Disease control TerminatedThis study tested a personalized approach for children with neuroblastoma that had come back or not responded to treatment. Doctors analyzed each child's tumor genes to pick a combination of targeted drugs. The goal was to control the cancer, not cure it, and the trial was stoppe…
Matched conditions: NEUROBLASTOMA
Phase: PHASE1 • Sponsor: Yael P Mosse • Aim: Disease control
Last updated May 22, 2026 14:05 UTC